Director & CHIEF EXECUTIVE OFFICER
Director & CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc., filing insider transactions between 2026-09-15 and 2026-09-17.
| SEC ↗ |
| 2026-09-16 | TVTX | Sale | 99.7K | $63.26 | $6.3M | SEC ↗ |
| 2026-09-15 | TVTX | Sale | 270 | $65.31 | $18K | SEC ↗ |
| 2026-09-15 | TVTX | Sale | 28.8K | $62.66 | $1.8M | SEC ↗ |
| 2026-09-15 | TVTX | Sale | 3,102 | $63.64 | $197K | SEC ↗ |
| 2026-09-15 | TVTX | Sale | 63.5K | $61.99 | $3.9M | SEC ↗ |